Merck filed suit against Teva Pharmaceuticals over a patent related to montelukast sodium granule formation for Merck’s “Singulair” product. 1/11, District of New Jersey, 3:2012cv00210.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
